Comparative hematology and coagulation: studies on rodentia (rats)

Area of Science:

• Comparative hematology
• Hemostasis research
• Rodent models in biomedical research

Background:

• Understanding rodent hemostasis is crucial for preclinical studies.
• Wistar rats are commonly used animal models, but their coagulation system is not fully characterized.
• Variations in coagulation can impact the interpretation of drug efficacy and toxicity studies.

Purpose of the Study:

• To comprehensively characterize the hemostatic profile of adult male Wistar rats.
• To compare key coagulation parameters and blood cell characteristics with those of normal humans.
• To identify potential differences that may influence their utility as models for human hemostasis.

Main Methods:

• Analysis of whole blood clotting times (serum prothrombin, plasma prothrombin, activated partial thromboplastin, thrombin, and reptilase times).
• Quantification of specific coagulation factors (II, V, VII, VIII:C, VIIIR:vW, IX, X, XI, XII, Fletcher factor) and anti-thrombin III.
• Assessment of platelet aggregation in response to various agonists.
• Enumeration and characterization of leukocytes and erythrocytes.

Main Results:

• Rat blood clotted rapidly, retracted, and did not lyse.
• Shorter prothrombin and activated partial thromboplastin times, but longer thrombin and reptilase times were observed, suggesting a thrombin inhibitor.
• Lower levels of coagulation factors X, VIIIR:vW, and IX, but higher levels of VIII:C and anti-thrombin III compared to humans.
• Platelets were small, numerous, aggregated well with ADP but poorly with other agonists.
• Erythrocytes were small and numerous; leukocyte counts were within the human range.

Conclusions:

• Wistar rats possess a distinct hemostatic profile compared to humans, characterized by rapid clotting and specific coagulation factor imbalances.
• Differences in platelet aggregation and the presence of a thrombin inhibitor warrant consideration in research.
• These findings are vital for interpreting preclinical data and selecting appropriate animal models for hemostasis and thrombosis research.